KL Acquisition Corp
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KLAQ research report →
Company
KL Acquisition Corp is a blank check company. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. It intends to focus investment effort on life sciences, which includes medical devices, diagnostics, and life sciences tools and instrumentation.
- CEO
- Richard Gumer
- IPO
- 2021
- HQ
- New York City, NY, US
Price Chart
Valuation
- Market Cap
- $0
- P/E
- 3.63
- P/S
- 0.00
- P/B
- 0.27
- EV/EBITDA
- -0.06
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 14.79%
- ROIC
- -0.29%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $19.99M · 0.00%
- EPS
- $2.78 · 0.00%
- Op Income
- $-833,000
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $10.11
- 52W Low
- $9.71
- 50D MA
- $10.02
- 200D MA
- $9.88
- Beta
- 0.00
- Avg Volume
- 102.54K
Get TickerSpark's AI analysis on KLAQ
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 7, 21 | KL Sponsor LLC | other | 7,067,500 |
| Jan 7, 21 | BIERMAN JAMES L | other | 30,000 |
| Jan 7, 21 | Casciaro Gregory D | other | 30,000 |
Our KLAQ Coverage
We haven't published any research on KLAQ yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate KLAQ Report →